Literature DB >> 10915953

The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.

.   

Abstract

The aim of the present work was to evaluate if the presence of a polyethylenglycol (PEG) coating around PLA nanoparticles would affect their interaction with biological surfaces, following oral administration to rats. For this purpose, a model antigen, 125I-radiolabeled tetanus toxoid, was encapsulated in PLA and PLA-PEG nanoparticles by a modified water-in-oil-in-water solvent evaporation technique. Firstly, the stability of the nanoparticles in simulated gastrointestinal fluids was evaluated. Results showed an interaction between the nanoparticles and the enzymes of the digestive fluids, this interaction being considerably reduced by the PEG coating around the particles. On the other hand, the PLA forming the nanoparticles was found to be only slightly degraded (9% converted to lactate for PLA nanoparticles and 3% for PLA-PEG nanoparticles) and that the encapsulated tetanus toxoid remained mostly associated to the nanoparticles upon incubation in the digestive fluids for up to 4 h. Finally, the in vivo experiments showed that, after oral administration to rats, the levels of encapsulated radioactive antigen in the blood stream and lymphatics were higher for PLA-PEG nanoparticles than for PLA nanoparticles. In conclusion, the PLA-PEG nanoparticles have a promising future as protein delivery systems for oral administration.

Entities:  

Year:  2000        PMID: 10915953     DOI: 10.1016/s0927-7765(99)00157-5

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  46 in total

1.  Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A.

Authors:  D D Ankola; A Battisti; R Solaro; M N V Ravi Kumar
Journal:  J R Soc Interface       Date:  2010-05-26       Impact factor: 4.118

2.  Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery.

Authors:  C Prego; M Fabre; D Torres; M J Alonso
Journal:  Pharm Res       Date:  2006-03-16       Impact factor: 4.200

Review 3.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

Review 4.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

Review 5.  Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.

Authors:  James D Fisher; Abhinav P Acharya; Steven R Little
Journal:  Clin Immunol       Date:  2015-05-01       Impact factor: 3.969

6.  Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.

Authors:  Debatosh Majumdar; Kyung-Ho Jung; Hongzheng Zhang; Sreenivas Nannapaneni; Xu Wang; A R M Ruhul Amin; Zhengjia Chen; Zhuo G Chen; Dong M Shin
Journal:  Cancer Prev Res (Phila)       Date:  2014-01

7.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

Review 8.  Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Authors:  Melike Uner; Gülgün Yener
Journal:  Int J Nanomedicine       Date:  2007

9.  Preparation and evaluation of poly(ethylene glycol)-poly(lactide) micelles as nanocarriers for oral delivery of cyclosporine a.

Authors:  Yanhui Zhang; Xinru Li; Yanxia Zhou; Xiaoning Wang; Yating Fan; Yanqing Huang; Yan Liu
Journal:  Nanoscale Res Lett       Date:  2010-03-27       Impact factor: 4.703

10.  Oral insulin delivery by means of solid lipid nanoparticles.

Authors:  Bruno Sarmento; Susana Martins; Domingos Ferreira; Eliana B Souto
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.